Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: specific effect of HAART on neopterin - Wikidata - awgldk - TriplyDB

Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: specific effect of HAART on neopterin

Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: specific effect of HAART on neopterin

http://www.wikidata.org/entity/Q33998654

about

Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients.Neopterin and Soluble CD14 Levels as Indicators of Immune Activation in Cases with Indeterminate Pattern and True Positive HIV-1 Infection Moderate-Intensity Exercise Improves Body Composition and Improves Physiological Markers of Stress in HIV-Infected Men.Utility of Serum Neopterin and Serum IL-2 Receptor Levels to Predict Absolute CD4 T Lymphocyte Count in HIV Infected Cases.Neopterin in Diagnosis and Monitoring of Infectious Diseases.Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction.

P2860

Q34412376-25BEA113-1A17-4790-801B-51BB3F86C769 Q34631665-4F5C8A91-F51A-4DEE-8691-F6C4EE0C2495 Q35975337-80ED990A-5216-4C9C-971A-C214AE4EF48A Q37156629-CD1FF787-6F38-4E85-BFD6-815DD4AF129A Q37408032-235FAE9F-766F-4FCC-AA9F-D82974F14F16 Q38575775-0D7C4E5B-969A-4662-92FB-67670B2F9646 Q43967318-5D7A2CFE-69F1-4AF9-A689-F6AA6414937F Q54224356-9F387979-008B-4C7F-B8E4-BB5121E63F9A

P2860

Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: specific effect of HAART on neopterin

http://www.wikidata.org/entity/Q33998654

description

2000 nî lūn-bûn

@nan

2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Highly active antiretroviral t ...... c effect of HAART on neopterin

@ast

Highly active antiretroviral t ...... c effect of HAART on neopterin

@en

type

label

Highly active antiretroviral t ...... c effect of HAART on neopterin

@ast

Highly active antiretroviral t ...... c effect of HAART on neopterin

@en

prefLabel

Highly active antiretroviral t ...... c effect of HAART on neopterin

@ast

Highly active antiretroviral t ...... c effect of HAART on neopterin

@en

P1433

Q33998654-8999F6DF-C706-405D-B4A8-F5E906D59734

P1476

Q33998654-04527E1F-247D-4792-BEA9-D491D944E63A

P2093

Q33998654-28233E4A-0804-4CAD-974D-603A7C626525

Q33998654-2AA50575-AC7F-4940-873D-B401FA9B61FE

Q33998654-35E7439C-D409-402D-B514-37220DE9D7AF

Q33998654-96B6DF42-6A4C-4711-99B3-10A23E340261

Q33998654-9AED3208-A818-453C-895E-BAA44AF4A08C

Q33998654-D5832FF4-4EC4-4F87-B38E-075F646745D8

P2860

Q33998654-0E0C4F97-00EF-44F9-8299-05AA0F68B407

Q33998654-21E56107-4EBA-401A-9BFD-19085A8CF664

Q33998654-296CB19C-AF18-4815-92F2-8F887F45EC8B

Q33998654-54B3351B-585E-457B-92A6-ED764FC098D0

Q33998654-584E350D-1BC7-477E-944D-3CADD5966825

Q33998654-6B9466F8-D3FF-4804-A5AA-4829B73DB98D

Q33998654-6C07E5EC-9701-4059-89EF-373C632AC35F

Q33998654-7D013B08-A9C5-4D53-8931-6BB546E0708B

Q33998654-879A9CF9-B5DA-4592-81F0-70EA511BEE87

Q33998654-9FE10B97-6745-443B-8FC9-9CADBFD387FC

P304

Q33998654-B3504323-2E00-4C05-AC1A-3EEAFFBF4963

P31

Q33998654-78C40C98-621E-4614-87BA-D05C40B9E4BB

P356

Q33998654-F83F82B7-6206-4896-B6C3-8138B2E789D8

P433

Q33998654-8E1BECA2-E549-42C8-A794-4E96E1C71D1D

P478

Q33998654-594CD209-AAF3-4C6A-B724-21686B6B6ACA

P577

Q33998654-772E1E1C-5F0D-4704-AA92-97B3A66C7778

P698

Q33998654-155D6196-D35B-41EF-8214-40716CF44C62

P921

Q33998654-3BE8F518-F4B0-4F0A-83C9-AD38D1D0F07B

P932

Q33998654-2EE5BFD0-73BD-4409-91F1-A9BD0C5541A4

P356

CDLI.7.5.832-834.2000

P1433

Clinical and Vaccine Immunology

P1476

Highly active antiretroviral t ...... c effect of HAART on neopterin

@en

P2093

Amirayan-Chevillard N

http://www.w3.org/2001/XMLSchema#string

Capo C

http://www.w3.org/2001/XMLSchema#string

Gallais H

http://www.w3.org/2001/XMLSchema#string

Mege JL

http://www.w3.org/2001/XMLSchema#string

Obadia Y

http://www.w3.org/2001/XMLSchema#string

Tissot-Dupont H

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.

Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.

Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy.

Markers predicting progression of human immunodeficiency virus-related disease.

Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: a comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and beta2-microglobu

The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection.

Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change.

P304

832-834

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CDLI.7.5.832-834.2000

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10973464

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

95965

http://www.w3.org/2001/XMLSchema#string